1. Home
  2. ITRM vs HTCR Comparison

ITRM vs HTCR Comparison

Compare ITRM & HTCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITRM
  • HTCR
  • Stock Information
  • Founded
  • ITRM 2015
  • HTCR 2009
  • Country
  • ITRM Ireland
  • HTCR Japan
  • Employees
  • ITRM N/A
  • HTCR N/A
  • Industry
  • ITRM Biotechnology: Pharmaceutical Preparations
  • HTCR EDP Services
  • Sector
  • ITRM Health Care
  • HTCR Technology
  • Exchange
  • ITRM Nasdaq
  • HTCR Nasdaq
  • Market Cap
  • ITRM 49.5M
  • HTCR 48.1M
  • IPO Year
  • ITRM 2018
  • HTCR 2022
  • Fundamental
  • Price
  • ITRM $1.54
  • HTCR $1.49
  • Analyst Decision
  • ITRM Strong Buy
  • HTCR
  • Analyst Count
  • ITRM 1
  • HTCR 0
  • Target Price
  • ITRM $5.00
  • HTCR N/A
  • AVG Volume (30 Days)
  • ITRM 671.4K
  • HTCR 738.4K
  • Earning Date
  • ITRM 11-14-2024
  • HTCR 11-14-2024
  • Dividend Yield
  • ITRM N/A
  • HTCR 5.37%
  • EPS Growth
  • ITRM N/A
  • HTCR N/A
  • EPS
  • ITRM N/A
  • HTCR 0.23
  • Revenue
  • ITRM N/A
  • HTCR $30,290,930.00
  • Revenue This Year
  • ITRM N/A
  • HTCR $53.30
  • Revenue Next Year
  • ITRM N/A
  • HTCR N/A
  • P/E Ratio
  • ITRM N/A
  • HTCR $6.41
  • Revenue Growth
  • ITRM N/A
  • HTCR 47.63
  • 52 Week Low
  • ITRM $0.81
  • HTCR $0.45
  • 52 Week High
  • ITRM $3.02
  • HTCR $3.38
  • Technical
  • Relative Strength Index (RSI)
  • ITRM 39.39
  • HTCR 45.72
  • Support Level
  • ITRM $1.58
  • HTCR $1.53
  • Resistance Level
  • ITRM $2.10
  • HTCR $1.76
  • Average True Range (ATR)
  • ITRM 0.14
  • HTCR 0.39
  • MACD
  • ITRM -0.04
  • HTCR -0.06
  • Stochastic Oscillator
  • ITRM 11.11
  • HTCR 1.31

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents. The company operates as a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company. It provides software through two business units. The first business unit includes a customer experience management business that has been in existence for 12 years. The customer experience management platform includes marketing, sales, service and content management systems, as well as other tools and integrations, that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, its DX division, is a digital transformation business that provides customers with robotics process automation, process mining and task mining to accelerate the digital transformation of enterprises.

Share on Social Networks: